时隔5个月，华宝基金医疗ETF（512170）重新站上年线！药明康德A股突破上轮医药牛市高点，创上市8年新高！

新浪基金08-10

8月10日，A股医疗板块继续向上！AI医疗概念领涨，华大智造冲击20CM涨停，金域医学10%涨停封板。CXO再爆发，博腾股份、康龙化成续涨超5%，权重龙头药明康德A股盘中飙升逾7%，一举突破上轮医药牛市前高，创历史新高！　　全市场规模最大医疗ETF华宝（512170）继上日大涨4.53%后，盘中再度冲上4%，场内价格创本轮反弹新高，时隔5个月重新站上年线，不到半日成交额近10亿元！　　数据...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2658043626?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-08-10 11:17","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2658043626","market":"hk","top_or_hot":-1,"title":"时隔5个月，华宝基金医疗ETF（512170）重新站上年线！药明康德A股突破上轮医药牛市高点，创上市8年新高！","media":"新浪基金","content":"<div>\n<p>8月10日，A股医疗板块继续向上！AI医疗概念领涨，华大智造冲击20CM涨停，金域医学10%涨停封板。CXO再爆发，博腾股份、康龙化成续涨超5%，权重龙头药明康德A股盘中飙升逾7%，一举突破上轮医药牛市前高，创历史新高！\n\n　　全市场规模最大医疗ETF华宝（512170）继上日大涨4.53%后，盘中再度冲上4%，场内价格创本轮反弹新高，时隔5个月重新站上年线，不到半日成交额近10亿元！\n　　数据...</p>\n\n<a href=\"https://finance.sina.com.cn/money/fund/etf/2026-08-10/doc-inimuzxp1261719.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>时隔5个月，华宝基金医疗ETF（512170）重新站上年线！药明康德A股突破上轮医药牛市高点，创上市8年新高！</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n时隔5个月，华宝基金医疗ETF（512170）重新站上年线！药明康德A股突破上轮医药牛市高点，创上市8年新高！\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-10 11:17 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/money/fund/etf/2026-08-10/doc-inimuzxp1261719.shtml><strong>新浪基金</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月10日，A股医疗板块继续向上！AI医疗概念领涨，华大智造冲击20CM涨停，金域医学10%涨停封板。CXO再爆发，博腾股份、康龙化成续涨超5%，权重龙头药明康德A股盘中飙升逾7%，一举突破上轮医药牛市前高，创历史新高！\n\n　　全市场规模最大医疗ETF华宝（512170）继上日大涨4.53%后，盘中再度冲上4%，场内价格创本轮反弹新高，时隔5个月重新站上年线，不到半日成交额近10亿元！\n　　数据...</p>\n\n<a href=\"https://finance.sina.com.cn/money/fund/etf/2026-08-10/doc-inimuzxp1261719.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1251922891.USD","symbol_name":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) ACC","start_time":0,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-10/doc-inimuzxp1261719.shtml","article_id":"2658043626","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2658043626","pubTimestamp":1786331820,"columns":[{"name":"A股","id":33,"label_key":"policyRegulatory"}],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"8月10日，A股医疗板块继续向上！CXO再爆发，博腾股份、康龙化成续涨超5%，权重龙头药明康德A股盘中飙升逾7%，一举突破上轮医药牛市前高，创历史新高！全市场规模最大医疗ETF华宝继上日大涨4.53%后，盘中再度冲上4%，场内价格创本轮反弹新高，时隔5个月重新站上年线，不到半日成交额近10亿元！数据显示，医疗ETF华宝标的指数覆盖8只CXO龙头股，最新权重合计32.82%，其中药明康德占比13.42%。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159828":"医疗ETF","159938":"医药","159982":"中证500","399300":"沪深300","512170":"医疗ETF华宝","603259":"药明康德","LU1251922891.USD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) ACC","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","LU1997245177.USD":"安联神洲A股基金","LU1808992512.USD":"AB ALL CHINA EQUITY PORTFOLIO \"A\" (USD) ACC","IE00B543WZ88.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) ACC","BK1576":"医药外包概念","BK1141":"生命科学工具和服务","LU0700851271.USD":"NINETY ONE GSF EMERGING MARKETS MULTI-ASSET \"A\" (USD) ACC","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","LU1303224171.USD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) INC","BK1161":"生物科技","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU1719994722.HKD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (HKD) ACC","02359":"药明康德","LU0052750758.USD":"富兰克林中国基金A Acc","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","IPOS":"Renaissance International IPO ETF","LU1770034418.SGD":"ALL CHINA EQUITY \"A\" (SGDHDG) ACC","LU0611395673.USD":"NINETY ONE GSF EMERGING MARKETS EQUITY \"A\" (USD) ACC","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","09939":"开拓药业-B","BK1515":"抗疫概念","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","IE00B5MMRT66.SGD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (SGDHDG) ACC","BK1574":"生物医药B类股","LU1934453819.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"A\" (USD) ACC","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU2495084118.USD":"ALLIANZ CHINA A-SHARES \"ATH\" (USDHDG) ACC","LU1979443071.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"AD\" (USDHDG) INC","LU0348766576.USD":"ALLIANZ LITTLE DRAGONS \"A\" (USD) INC","LU1046422090.SGD":"Fidelity Pacific A-SGD","LU1997244956.HKD":"ALLIANZ CHINA A-SHARES \"AT\" (HKD) ACC A","BK0216":"研究试验","BK1583":"高瓴概念","LU0348767384.USD":"ALLIANZLITTLE DRAGONS \"A\" (USD) ACC","IE00BPRC5H50.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) INC","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD"},"translate_title":"After 5 months, Huabao Fund Medical ETF (512170) is back on the annual line! WuXi AppTec A shares broke through the high of the last round of pharmaceutical bull market, hitting a new high in 8 years of listing!","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159828":1.5,"159938":1.5,"159982":1.5,"399300":1.5,"512170":1.5,"603259":1.5,"IPOS":1.5,"02359":1.5,"09939":1.5},"content_text":"8月10日，A股医疗板块继续向上！AI医疗概念领涨，华大智造冲击20CM涨停，金域医学10%涨停封板。CXO再爆发，博腾股份、康龙化成续涨超5%，权重龙头药明康德A股盘中飙升逾7%，一举突破上轮医药牛市前高，创历史新高！\n\n　　全市场规模最大医疗ETF华宝（512170）继上日大涨4.53%后，盘中再度冲上4%，场内价格创本轮反弹新高，时隔5个月重新站上年线，不到半日成交额近10亿元！\n　　数据显示，医疗ETF华宝（512170）标的指数覆盖8只CXO龙头股，最新权重合计32.82%，其中药明康德占比13.42%。\n\n　　消息面，药明康德再迎重磅利好！据8月9日公告，美国法院就公司的初步禁令动议作出裁决，挑战1260H认定期间免受不利影响。\n　　上周公司披露超预期半年报：归母净利润历史首次在上半年突破百亿元，达110.8亿元，同比增长29.43%；Q2单季营收165亿创历史新高。公司上调2026年全年营收预测至人民币585-605亿元，持续经营业务收入同比增速上调至35%-39%。\n　　此外，近期强生、赛诺菲、BMS、诺华、罗氏等多家海外MNC与CXO披露中报盈喜并上调2026年全年指引，CDMO与CRO订单、收入及盈利表现持续改善。\n　　中信建投研报认为， 2026年至今国内创新药行业的长期结构性机会持续兑现，国内投融资持续改善，新药物形式赛道持续火热并进一步放量，国内CRO/CDMO行业的新签订单及业绩会加速增长，带动CXO产业链进入新一轮发展阶段。\n　　高效参与CXO交易，关注两大“利器”：\n　　医疗ETF华宝（512170）：全市场规模最大医药医疗类ETF，聚焦医疗器械（含脑机接口）+医疗服务（CXO含量近30%），兼顾AI医疗概念。场外联接基金：012323。\n　　港股通医疗ETF华宝（159137）：重仓创新药产业链，48%CXO+20%创新药，兼顾AI医疗、医疗器械（含脑机接口）等领域稀缺龙头，底层资产是港股，高弹性，T+0。场外联接基金：026922。\n\n　　数据来源于沪深交易所、中证指数公司等，权重数据截至2026.7.31。机构观点：东北证券20260727《东北医疗大健康周报：持续看好创新药械为中长期主线AI医疗已迎来价值兑现窗口》。兴业证券20260803《兴证医药行业2026年8月投资月报》\n　　注：文中ETF基金均不收取销售服务费。基金费率详见各基金法律文件。\n　　风险提示：文中指数成份股仅作展示，个股描述不作为任何形式的投资建议，也不代表管理人旗下任何基金的持仓信息和交易动向，标的指数成份股构成根据该指数编制规则适时调整。基金管理人评估的港股通医疗ETF华宝、医疗ETF华宝联接基金的风险等级为R4-中高风险，适宜积极型（C4）及以上投资者，医疗ETF华宝的风险等级为R3-中风险，适宜平衡型（C3）及以上的投资者。任何在本文出现的信息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，投资人须对任何自主决定的投资行为负责。另，本文中的任何观点、分析及预测不构成对阅读者任何形式的投资建议，亦不对因使用本文内容所引发的直接或间接损失负任何责任。基金投资有风险，基金的过往业绩并不代表其未来表现，基金管理人管理的其他基金的业绩并不构成基金业绩表现的保证，基金投资须谨慎。\n\nMACD金叉信号形成，这些股涨势不错！","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2658043626","isCrawlerRequest":true}